AJP - Endo Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 269: E478-E488, 1995;
0193-1849/95 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Porksen, N.
Right arrow Articles by Butler, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Porksen, N.
Right arrow Articles by Butler, P.

AJP - Endocrinology and Metabolism, Vol 269, Issue 3 E478-E488, Copyright © 1995 by American Physiological Society

ARTICLES

Pulsatile insulin secretion accounts for 70% of total insulin secretion during fasting

N. Porksen, S. Munn, J. Steers, S. Vore, J. Veldhuis and P. Butler
Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905, USA.

The purpose of the present study was to determine the contributions of discrete insulin secretory bursts vs. basal insulin release to total insulin secretion in vivo. Quantification of the partitioning of pulsatile and basal insulin secretion is complicated by physiological delivery of these pulses into the portal vein and the absence of validated methods of measuring the rates of pulsatile and basal insulin secretion in vivo. We therefore 1) developed a canine model with chronically implanted portal vein catheters, 2) validated an established deconvolution technique as well as a novel direct catheterization technique (Clustcath) for measurement of pulsatile and nonpulsatile insulin secretion rates in this model, and 3) applied these methods to study insulin secretion in the overnight-fasted dog in vivo to determine the contribution of pulsatile vs. basal insulin secretion to total rates of endogenous insulin secretion. Rates of total, pulsatile, and nonpulsatile endogenous insulin secretion measured by Cluscath closely parallel those measured by deconvolution analysis (54 +/- 15 vs. 51 +/- 11, 38 +/- 12 vs. 36 +/- 11, and 16 +/- 4 vs. 14 +/- 4 pmol/min, respectively). Clustcath and deconvolution indicated that the majority of insulin was secreted as pulses (70 +/- 6 and 66 +/- 7%, respectively). These data infer that any process that selectively decreases the pulsatile component of insulin secretion (e.g., diabetes mellitus) will likely have a major impact on total insulin secretion.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. Bertram, A. Sherman, and L. S. Satin
Metabolic and electrical oscillations: partners in controlling pulsatile insulin secretion
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E890 - E900.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A.-M. T. Richard, D.-L. Webb, J. M. Goodman, V. Schultz, J. N. Flanagan, L. Getty-Kaushik, J. T. Deeney, G. C. Yaney, G. A. Dunaway, P.-O. Berggren, et al.
Tissue-dependent loss of phosphofructokinase-M in mice with interrupted activity of the distal promoter: impairment in insulin secretion
Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E794 - E801.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. V. Matveyenko and P. C. Butler
{beta}-Cell Deficit Due to Increased Apoptosis in the Human Islet Amyloid Polypeptide Transgenic (HIP) Rat Recapitulates the Metabolic Defects Present in Type 2 Diabetes.
Diabetes, July 1, 2006; 55(7): 2106 - 2114.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. S. Mao, N. Berman, and E. Ipp
Loss of entrainment of high-frequency plasma insulin oscillations in type 2 diabetes is likely a glucose-specific {beta}-cell defect
Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E50 - E54.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
I. Lundquist, P. Alm, A. Salehi, R. Henningsson, E. Grapengiesser, and B. Hellman
Carbon monoxide stimulates insulin release and propagates Ca2+ signals between pancreatic {beta}-cells
Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E1055 - E1063.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. C. Lovejoy, S. R. Smith, C. M. Champagne, M. M. Most, M. Lefevre, J. P. DeLany, Y. M. Denkins, J. C. Rood, J. Veldhuis, and G. A. Bray
Effects of Diets Enriched in Saturated (Palmitic), Monounsaturated (Oleic), or trans (Elaidic) Fatty Acids on Insulin Sensitivity and Substrate Oxidation in Healthy Adults
Diabetes Care, August 1, 2002; 25(8): 1283 - 1288.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J.-M. Lin, M. E. Fabregat, R. Gomis, and P. Bergsten
Pulsatile Insulin Release From Islets Isolated From Three Subjects With Type 2 Diabetes
Diabetes, April 1, 2002; 51(4): 988 - 993.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. Bergsten, J. Westerlund, P. Liss, and P.-O. Carlsson
Primary In Vivo Oscillations of Metabolism in the Pancreas
Diabetes, March 1, 2002; 51(3): 699 - 703.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
N. Porksen, T. Grofte, J. Greisen, A. Mengel, C. Juhl, J. D. Veldhuis, O. Schmitz, M. Rossle, and H. Vilstrup
Human insulin release processes measured by intraportal sampling
Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E695 - E702.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. B. Juhl, M. Hollingdal, J. Sturis, G. Jakobsen, H. Agerso, J. Veldhuis, N. Porksen, and O. Schmitz
Bedtime Administration of NN2211, a Long-Acting GLP-1 Derivative, Substantially Reduces Fasting and Postprandial Glycemia in Type 2 Diabetes
Diabetes, February 1, 2002; 51(2): 424 - 429.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. Gilon, M. A. Ravier, J.-C. Jonas, and J.-C. Henquin
Control Mechanisms of the Oscillations of Insulin Secretion In Vitro and In Vivo
Diabetes, February 1, 2002; 51(90001): S144 - 151.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
N. Porksen, M. Hollingdal, C. Juhl, P. Butler, J. D. Veldhuis, and O. Schmitz
Pulsatile Insulin Secretion: Detection, Regulation, and Role in Diabetes
Diabetes, February 1, 2002; 51(90001): S245 - 254.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. Juhl, T. Grofte, P. C. Butler, J. D. Veldhuis, O. Schmitz, and N. Porksen
Effects of Fasting on Physiologically Pulsatile Insulin Release in Healthy Humans
Diabetes, February 1, 2002; 51(90001): S255 - 257.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
L. L. Kjems, B. M. Kirby, E. M. Welsh, J. D. Veldhuis, M. Straume, S. S. McIntyre, D. Yang, P. Lefebvre, and P. C. Butler
Decrease in {beta}-Cell Mass Leads to Impaired Pulsatile Insulin Secretion, Reduced Postprandial Hepatic Insulin Clearance, and Relative Hyperglucagonemia in the Minipig
Diabetes, September 1, 2001; 50(9): 2001 - 2012.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. J. Vore, E. D. Aycock, J. D. Veldhuis, and P. C. Butler
Anesthesia rapidly suppresses insulin pulse mass but enhances the orderliness of insulin secretory process
Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E93 - E99.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. Ritzel, M. Schulte, N. Pørksen, M. S. Nauck, J. J. Holst, C. Juhl, W. März, O. Schmitz, W. H. Schmiegel, and M. A. Nauck
Glucagon-Like Peptide 1 Increases Secretory Burst Mass of Pulsatile Insulin Secretion in Patients With Type 2 Diabetes and Impaired Glucose Tolerance
Diabetes, April 1, 2001; 50(4): 776 - 784.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
T. Laedtke, L. Kjems, N. Porksen, O. Schmitz, J. Veldhuis, P. C. Kao, and P. C. Butler
Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes
Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E520 - E528.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
N. Porksen, C. Juhl, M. Hollingdal, S. M. Pincus, J. Sturis, J. D. Veldhuis, and O. Schmitz
Concordant induction of rapid in vivo pulsatile insulin secretion by recurrent punctuated glucose infusions
Am J Physiol Endocrinol Metab, January 1, 2000; 278(1): E162 - E170.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. C. Lovejoy, S. R. Smith, J. J. Zachwieja, G. A. Bray, M. M. Windhauser, P. J. Wickersham, J. D. Veldhuis, R. Tulley, and J. A. de la Bretonne
Low-dose T3 improves the bed rest model of simulated weightlessness in men and women
Am J Physiol Endocrinol Metab, August 1, 1999; 277(2): E370 - E379.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
P. Bergsten
Glucose-induced pulsatile insulin release from single islets at stable and oscillatory cytoplasmic Ca2+
Am J Physiol Endocrinol Metab, May 1, 1998; 274(5): E796 - E800.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
N. Porksen, B. Nyholm, J. D. Veldhuis, P. C. Butler, and O. Schmitz
In humans at least 75% of insulin secretion arises from punctuated insulin secretory bursts
Am J Physiol Endocrinol Metab, November 1, 1997; 273(5): E908 - E914.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
D. Fliser, F. Schaefer, D. Schmid, J. D. Veldhuis, and E. Ritz
Angiotensin II Affects Basal, Pulsatile, and Glucose-Stimulated Insulin Secretion in Humans
Hypertension, November 1, 1997; 30(5): 1156 - 1161.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online